To investigate the role of CD2AP in AD, we first checked CD2AP protein levels reported in a proteomic study with large datasets [53] and found that CD2AP was significantly increased in the brain of AD patients compared to control subjects and asymptomatic AD patients (Fig. 1A). The gene discussed is CD2AP; the disease is Alzheimer disease.